A. D. de Carvalho

Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

B. Horta, A. D. de Carvalho, R. Duquia, 2016, Drugs in R&D.

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council

B. Strober, J. M. van der Walt, P. C. van de Kerkhof, 2019, American Journal of Clinical Dermatology.

Recommendations on the use of biosimilars by the Brazilian Society of Rheumatology, Brazilian Society of Dermatology, Brazilian Federation of Gastroenterology and Brazilian Study Group on Inflammatory Bowel Disease--Focus on clinical evaluation of monoclonal antibodies and fusion proteins used in th

S. Miszputen, R. Romiti, A. D. de Carvalho, 2015, Autoimmunity reviews.

Saliva may be a diagnostic source of quality of life in psoriasis measured by Fourier transform infrared spectroscopy (FTIR) and chemometrics.

A. D. de Carvalho, V. Corbellini, Jaquelini Barboza da Silva, 2022, Photodiagnosis and photodynamic therapy.

Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil

A. D. de Carvalho, R. Bonamigo, C. da Silva, 2012, International journal of dermatology.

Dermoscopic clues in the diagnosis of amelanotic and hypomelanotic malignant melanoma*

A. D. de Carvalho, M. S. Ferreira, R. Steglich, 2012, Anais brasileiros de dermatologia.

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology*

A. D. de Carvalho, H. Cheinquer, Luana Pizarro Meneghello, 2014, Anais brasileiros de dermatologia.

Psoriasis comorbidities: complications and benefits of immunobiological treatment*

R. Romiti, A. D. de Carvalho, C. S. Souza, 2016, Anais brasileiros de dermatologia.